"アジュバント" の関連情報検索結果
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD - Urology Times

The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD Urology Times
ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC - Oncodaily

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC Oncodaily
Adjuvant Durvalumab in Resected Early-Stage NSCLC - The ASCO Post

Adjuvant Durvalumab in Resected Early-Stage NSCLC The ASCO Post
Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vac...

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - The New England Journal of...

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer The New England Journal of Medicine
Adjuvant Nivolumab Plus Chemo Decreases Disease Relapse Rates vs Chemo in Resected NSCLC - OncLive

Adjuvant Nivolumab Plus Chemo Decreases Disease Relapse Rates vs Chemo in Resected NSCLC OncLive
ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter ...

World-first library of vaccine-enhancing adjuvants launches - CEPI

World-first library of vaccine-enhancing adjuvants launches CEPI
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy:...

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial American Heart Association Journals
Adjuvant Pembrolizumab in Merkel Cell Carcinoma - The ASCO Post

Adjuvant Pembrolizumab in Merkel Cell Carcinoma The ASCO Post
A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics - Nature

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics Nature
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098...

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC - The ASCO Post

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC The ASCO Post
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized ph...

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC - The ASCO Post

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC The ASCO Post
Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through...

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer...

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer The ASCO Post
Discovery of a small molecule TLR3 agonist adjuvant - Nature

Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy sel...

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization...

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Orop...

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC - OncLive

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC OncLive
Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score ...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy - T...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy The ASCO Post
HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female m...

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer - The New England Journal of Med...

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer The New England Journal of Medicine
Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC? ...

Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC? ASCO Daily News
Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screeni...

Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screening Nature
Adjuvant S-1 plus endocrine therapy for ER-positive, HER2-negative, primary breast cancer: post-P...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer - The A...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer The ASCO Post
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against...

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma - The New England J...

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma The New England Journal of Medicine
Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Out...

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes The ASCO Post
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy...

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy The ASCO Post
Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-...

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopha...

Investigation of an algae-derived polymer as a pollinator-friendly pesticide adjuvant - Nature

Investigation of an algae-derived polymer as a pollinator-friendly pesticide adjuvant Nature
Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protect...

Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the...

Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cer...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer The ASCO Post
Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung ca...

Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung cancer ESMO Daily Reporter
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 y...

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer - On...

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer OncLive
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as mol...

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time? - ESMO Daily Reporter

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time? ESMO Daily Reporter
Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds - Georgia S...

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds Georgia State University News
A cowpea mosaic virus adjuvant conjugated to liposomes loaded with tumor cell lysates as an ovari...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer as...

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma Cleveland Clinic
Can Improving Adjuvant Endocrine Therapy Persistence Improve Survival Outcomes for Patients With ...

Can Improving Adjuvant Endocrine Therapy Persistence Improve Survival Outcomes for Patients With Early-Stage Breast Cancer? ASCO Publications
What is the role of adjuvant immunotherapy in contemporary melanoma care? - ESMO Daily Reporter

What is the role of adjuvant immunotherapy in contemporary melanoma care? ESMO Daily Reporter
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival a...

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae ...

Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and surv...

Adding adjuvant pertuzumab demonstrates prolonged survival benefit after 10+ years in HER2+ breas...

Adding adjuvant pertuzumab demonstrates prolonged survival benefit after 10+ years in HER2+ breast cancer ESMO Daily Reporter
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions ...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions on How to Optimize Benefits ASCO Daily News
Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype? - ASCO Daily News

Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype? ASCO Daily News
Linking vaccine adjuvant mechanisms of action to function - Science | AAAS

Linking vaccine adjuvant mechanisms of action to function Science | AAAS
Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer - Ur...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer UroToday
ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide - UroToday

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide UroToday
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma - The New Engla...

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma The New England Journal of Medicine
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journa...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma The New England Journal of Medicine
Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - The New England Jou...

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer The New England Journal of Medicine
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - The New England Journal of...

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma The New England Journal of Medicine
Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine National Institutes of Health (NIH) | (.gov)
The scientific journey of a novel adjuvant (AS37) from bench to bedside - Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside Nature
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - The New England Journal of Med...

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma The New England Journal of Medicine
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England...

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma The New England Journal of Medicine
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - The New England J...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer The New England Journal of Medicine
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma - NEJM Evidence

Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma NEJM Evidence
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - The New England Journ...

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma The New England Journal of Medicine
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - The New England Jou...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer The New England Journal of Medicine
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3...

Adjuvant T-DM1 vs Trastuzumab for Residual HER2-Positive Breast Cancer Overall Survival in KATHER...

Adjuvant T-DM1 vs Trastuzumab for Residual HER2-Positive Breast Cancer Overall Survival in KATHERINE The ASCO Post
Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National C...

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer National Cancer Institute (.gov)
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer Nature
Engineered immunogen binding to alum adjuvant enhances humoral immunity - Nature

Engineered immunogen binding to alum adjuvant enhances humoral immunity Nature
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma - The New England Journal of...

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma The New England Journal of Medicine
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - The New England Journ...

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma The New England Journal of Medicine
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - The New England Journal...

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy The New England Journal of Medicine
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - The New England Jou...

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma The New England Journal of Medicine
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma - Nature

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Nature
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - The New England Journal of ...

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer The New England Journal of Medicine
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a S...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New Englan...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer The New England Journal of Medicine
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - The New England Jo...

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer The New England Journal of Medicine
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to ...

Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma - Frontiers

Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma Frontiers
Adjuvant Radiation for Pathologically Node-Positive Prostate Cancer: Evidence When Early Salvage ...

Adjuvant Radiation for Pathologically Node-Positive Prostate Cancer: Evidence When Early Salvage May Not Be Early Enough ASCO Publications
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - The New Englan...

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer The New England Journal of Medicine
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma - Nature

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma Nature
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, pha...

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally de...

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer - The New England Journa...

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer The New England Journal of Medicine
Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer - ASCO Publications

Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer ASCO Publications